A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
Clinical trial NCT06307925 · RECRUITING
Trial details
- NCT number
- NCT06307925
- Sponsor
- HC Biopharma Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2025-12-31
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.